June 18, 2024 | BioSpace
Roche Inks Potential $1.8B Deal With Ascidian to Develop RNA Exon Therapies
June 18, 2024 | Endpoints
Roche strikes neuro-focused partnership with RNA exon editing startup, worth as much as $1.8B
June 18, 2024 | BiotechTV
Ascidian Therapeutics’ CEO discusses today’s collaboration with Roche on the company’s RNA exon editing technology for neurological conditions
June 18, 2024 | Fierce Biotech
Roche wades deeper into RNA waters, paying Ascidian $42M to develop exon editing drugs
June 18, 2024 | Genetic Engineering and Biotechnology News